TREATMENT OF C-MYC/BCL2 DOUBLE EXPRESSER DLBCL WITH R-CHOP CHEMOIMMUNOTHERAPY: AN AUSTRALIAN SINGLE CENTRE EXPERIENCE

被引：0
|
作者：
Ng, T. F. [1 ,2 ]
Whiteside, A. [3 ]
Rose, H. [1 ]
Kipp, D. [1 ]
Tawfik, B. [3 ]
Campbell, P. [1 ,4 ]
机构：
[1] Univ Hosp Geelong, Clin Haematol, Geelong, Vic, Australia
[2] Fiona Stanley Hosp, Haematol, Perth, WA, Australia
[3] St John God Pathol, Anat Pathol, Geelong, Vic, Australia
[4] Deakin Univ, Sch Med, Geelong, Vic, Australia
来源：
HAEMATOLOGICA | 2016年 / 101卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PB1724
引用
收藏
页码：701 / 701
页数：1
相关论文
共 37 条
  • [21] Retrospective Analysis of Clinical Outcomes of Utilizing R-CHOP Plus Zanubrutinib for High-Risk Diffuse Large B Cell Lymphoma Patients with Extranodal Involvement or MYC/BCL2 Double Expression
    Fu, Wanbin
    Liu, Jia
    Xiao, Dan
    Zhao, Huanbin
    Wang, Ting
    Hu, Jiong
    Hou, Jian
    Zhong, Hua
    Xu, Lan
    BLOOD, 2023, 142
  • [22] Tucidinostat plus R-CHOP in previously untreated diffuse large B-cell lymphoma with double expression of MYC and BCL2: An interim analysis from the phase III DEB study.
    Zhao, Weili
    Zhu, Jun
    Song, Yuqin
    Xu, Peng-Peng
    Shen, Jianzhen
    Cai, Qingqing
    Zhou, Hui
    Zhang, Liling
    Xiang, Ying
    Sun, Xiuhua
    Yang, Wei
    Yao, Zhihua
    Jing, Hongmei
    Wen, Shujuan
    Jin, Jie
    Xue, Hongwei
    Cen, Hong
    Ding, Kaiyang
    Jin, Zhengming
    Xing, Xiaojing
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (17_SUPPL) : LBA7003 - LBA7003
  • [23] Co-Expression of MYC and BCL2 Protein in R-CHOP Treated De Novo Diffuse Large B-Cell Lymphoma Predicts Poor Outcome
    Slack, G. W.
    Tan, K. L.
    Scott, D. W.
    Ben-Neriah, S.
    Johnson, N. A.
    Sehn, L. H.
    Connors, J. M.
    Gascoyne, R. D.
    LABORATORY INVESTIGATION, 2012, 92 : 370A - 370A
  • [24] Rituximab plus CHOP (R-CHOP) in the treatment of elderly patients with diffuse large B-cell lLymphoma (DLBCL) overcomes Bcl2-associated chemotherapy resistance.
    Mounier, N
    Briere, J
    Gisselbrecht, C
    Gaulard, P
    Lederlin, P
    Sebban, C
    Bosly, A
    Morel, P
    Tilly, H
    Bouabdallah, R
    Reyes, F
    Coiffier, B
    BLOOD, 2002, 100 (11) : 161A - 161A
  • [25] Real world data on young patients with high-risk diffuse large B-cell lymphoma treated with R-CHOP or R-CHOEP - MYC, BCL2 and BCL6 as prognostic biomarkers
    Pedersen, Mette Olgod
    Gang, Anne Ortved
    Brown, Peter
    Pedersen, Michael
    Knudsen, Helle
    Nielsen, Signe Ledou
    Poulsen, Tim
    Klausen, Tobias Wirenfeldt
    Hogdall, Estrid
    Norgaard, Peter
    PLOS ONE, 2017, 12 (10):
  • [26] Outcomes of patients with double/triple expressor diffuse large B-cell lymphoma (DLBCL) treated with R-DA-EPOCH/R-CHOP: A single-center experience
    Soomar, S. M.
    ANNALS OF ONCOLOGY, 2021, 32 : S777 - S777
  • [27] Outcomes of patients with double/triple expressor diffuse large B-cell lymphoma (DLBCL) treated with R-DA-EPOCH/R-CHOP: A single-center experience.
    Devi, Kanta
    Shaikh, Muhammad Usman
    Ali, Natasha Bahadur
    Adil, Salman Naseem
    Khan, Maria
    Soomar, Salman Muhammad
    LEUKEMIA RESEARCH REPORTS, 2021, 16
  • [28] Efficacy of dose-adjusted EPOCH plus rituximab/R-CHOP regimens and the prognosis analysis in patients with MYC, BCL2/BCL6 gene copy number gain lymphoma and double-hit lymphoma: results from a single institution retrospective clinical study
    Ma, Qianwen
    Chang, Yu
    Li, Ling
    Li, Xin
    Wang, Xinhua
    Wu, Jingjing
    Fu, Xiaorui
    Sun, Zhenchang
    Yu, Hui
    Zhang, Xudong
    Zhou, Zhiyuan
    Nan, Feifei
    Li, Zhaoming
    Liu, Xiyang
    Zhao, Qian
    Li, Yang
    Zhang, Lan
    Zhang, Mingzhi
    Zhang, Lei
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 1363 - 1372
  • [29] Zanubrutinib Combined with R-CHOP in Previously Untreated Non-Germinal Center BCell (GCB) Diffuse Large B-Cell Lymphoma (DLBCL) Patients with BCL2 and MYC Protein Co-Expression: A Multicenter, Phase II Study
    Jin, Jia
    Wang, Yalan
    Wang, Xi
    Tang, Yonghong
    Zeng, Shan
    Du, Juan
    Cao, Junning
    BLOOD, 2023, 142
  • [30] De-Novo Diffuse Large B Cell Lymphoma (DLBCL) Treated with Rituximab (R)-CHOP: Definition and Validation of a Prognostic Score Model Based on MYC, BCL2 and BCL6 Expression By Immunohistochemistry (IHC)
    Botto, Barbara
    Castellino, Alessia
    Chiappella, Annalisa
    Novo, Mattia
    Zattera, Luigi
    Cavallo, Federica
    Ghione, Paola
    Evangelista, Andrea
    Clochetto, Chiara
    Ciccone, Giovannino
    Scalzo, Maria Stella
    Chiarle, Roberto
    Novero, Domenico
    Vitolo, Umberto
    BLOOD, 2015, 126 (23)
1234